pumpe za endoskopiju
olympus d.o.o., zagreb - pumpe za endoskopiju
pumpe za i.v. terapiju i infuziju i pribor
de plano d.o.o., zagreb - volumetrijske pumpe i pribor za davanje i.v. terapije i infuzije
pumpe za i.v. terapiju i infuziju s priborom
mark medical d.o.o., zagreb - volumetrijske pumpe i pribor za davanje i.v. terapije i infuzije
infuzijske pumpe, setovi i pribor - moog curlin 4000 cms, moog curlin 6000 cms i moog curlin pain smart iod
pharmamed mado d.o.o., zagreb - pumpe i setovi za intravensko, epiduralno ili subkutano davanje otopina
controloc control
takeda gmbh - pantoprazol - gastroezofagealni refluks - inhibitori protonske pumpe - kratkoročno liječenje simptoma refluksa (npr. žgaravica, regurgitacija kiseline) u odraslih osoba.
blincyto
amgen europe b.v. - blinatumomab - prekursorska stanica limfoblastične leukemije-limfom - antineoplastična sredstva - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.